RethinkHIV researcher Dr. Anna Vassall of London School of Hygiene & Tropical Medicine is a signatory of a full-page advertisement in the New York Times with 266 other economists calling for greater health investment. The declaration states, “Our generation has a historic opportunity to achieve a ‘grand convergence’ in global health, reducing preventable maternal, child and infectious disease deaths to universally low levels by 2035.” Ahead of the adoption of the Global Goals at the United Nations in New York,...read full post
In a letter to the Lancet Global Health, London School of Hygiene & Tropical Medicine researchers Professor Charlotte Watts, Dr. Anna Vassall and Michelle Remme write that secondary schooling “might be as good an HIV investment as male circumcision. The RUSH-funded researchers, members of the RethinkHIV consortium, say that the relevant question is what level of co-investment in education from HIV budgets could be justified, in view of the benefits against HIV. Secondary education is a sound economic investment in its own right but remains resource-constrained in many low-income...read full post
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.